ArticleHealth science reports2026
Determinants of Zero-Dose Bacillus Calmette-Guérin Vaccination in Somaliland: A Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Zero-dose children face significant risks of vaccine-preventable diseases. This study aims to identify the sociodemographic, economic, and healthcare-related determinants of zero-dose BCG vaccination among children under 5 years of age in Somaliland. Methods: This cross-sectional study analyzed data from 2039 children from the 2020 Somaliland Demographic and Health Survey (SLDHS). We employed bivariate analysis (chi-square tests) and multivariate logistic regression to identify predictors of BCG vaccination. Results: Overall BCG coverage was 72.5%. Adjusted analysis revealed that facility-based delivery (AOR = 4.50; 95% CI: 3.51-5.77), maternal secondary education (AOR = 2.15; 95% CI: 1.25-3.70), and the highest wealth quintile (AOR = 3.10; 95% CI: 2.35-4.09) were significant predictors of BCG receipt. Conclusion: Facility delivery is the most critical intervention point to prevent zero-dose status. Strengthening maternal health integration and targeted outreach to marginalized populations are essential to reducing vaccination disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.